ArticleFrontiers in endocrinology2026
Curative outcomes with metal-containing TCM in diabetic foot ulcers unresponsive to standard therapy: a case series.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic foot ulcers (DFUs) are among the most severe complications of diabetes, often resulting in prolonged healing, recurrent infections, and a high risk of amputation. Despite comprehensive standard treatments, many patients develop chronic non-healing ulcers due to poor tissue perfusion and immune dysregulation. Traditional Chinese medicine, such as Huafu Shengji ointment (HFSJO), offers a novel topical approach that may promote tissue repair and accelerate healing in refractory cases. Case presentation: This report describes four patients with persistent DFUs that responded poorly to conventional therapies and faced either prior amputation or an imminent risk of amputation. Ulcer sizes ranged from 3.0 cm × 3.0 cm to 7.0 cm × 5.0 cm, with comorbidities including hypertension and cardiovascular disease. In addition to routine wound care, patients received topical HFSJO treatment every other day. Within 30-180 days, all wounds showed substantial granulation, epithelialization, and eventual closure. No clinically significant abnormalities in the liver or renal function tests or routine hematological parameters were observed during treatment or follow-up. Conclusion: Topical application of HFSJO appears to be a safe and effective conservative strategy for the management of complex DFUs, particularly in patients unsuitable for surgery or unresponsive to standard care. Through its dual mechanism, i.e., targeted debridement and regenerative stimulation, it may help overcome healing stagnation. These cases offer a promising direction for integrative wound care and warrant further validation in controlled clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.